Ole L. Dollerup

731 total citations
12 papers, 452 citations indexed

About

Ole L. Dollerup is a scholar working on Physiology, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Ole L. Dollerup has authored 12 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Geriatrics and Gerontology and 4 papers in Oncology. Recurrent topics in Ole L. Dollerup's work include Sirtuins and Resveratrol in Medicine (4 papers), Adipose Tissue and Metabolism (4 papers) and Artificial Intelligence in Healthcare and Education (3 papers). Ole L. Dollerup is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Adipose Tissue and Metabolism (4 papers) and Artificial Intelligence in Healthcare and Education (3 papers). Ole L. Dollerup collaborates with scholars based in Denmark, United Kingdom and United States. Ole L. Dollerup's co-authors include Niels Jessen, Jonas T. Treebak, Niels Møller, Steffen Ringgaard, Britt Christensen, Hans Stødkilde‐Jørgensen, Mads Svart, Karolina Sulek, Charles Brenner and Mark S. Schmidt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Ole L. Dollerup

10 papers receiving 444 citations

Peers

Countries citing papers authored by Ole L. Dollerup

Since Specialization

Citations

This map shows the geographic impact of Ole L. Dollerup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole L. Dollerup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole L. Dollerup more than expected).

Fields of papers citing papers by Ole L. Dollerup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole L. Dollerup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole L. Dollerup. The network helps show where Ole L. Dollerup may publish in the future.

Co-authorship network of co-authors of Ole L. Dollerup

This figure shows the co-authorship network connecting the top 25 collaborators of Ole L. Dollerup. A scholar is included among the top collaborators of Ole L. Dollerup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole L. Dollerup. Ole L. Dollerup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Navigating fairness aspects of clinical prediction models 2025 ·BMC Medicine ·(unknown), (unknown), (unknown), Ole L. Dollerup, (unknown), (unknown), Mikkel Malham, Tri‐Long Nguyen, Ádám Hulmán, Tibor V. Varga	0
2	GH replacement therapy in adults stimulates fibroblast activation protein-α activity 2025 ·European Journal of Endocrinology ·(unknown), A. K. Pedersen, (unknown), Ole L. Dollerup, (unknown), Niels Jessen, Mette Bjerre, Jens Otto Lunde Jørgensen	0
3	ChatGPT- versus human-generated answers to frequently asked questions about diabetes: A Turing test-inspired survey among employees of a Danish diabetes center 2023 ·PLoS ONE ·Ádám Hulmán, Ole L. Dollerup, (unknown), Matthew Fenech, (unknown), Henrik Støvring, Troels Krarup Hansen	26
4	Perception of artificial intelligence-based solutions in healthcare among people with and without diabetes: A cross-sectional survey from the health in Central Denmark cohort 2022 ·SHILAP Revista de lepidopterología ·(unknown), Ravi Aggarwal, Else‐Marie Dalsgaard, (unknown), Ole L. Dollerup, Hutan Ashrafian, Daniel R. Witte, Annelli Sandbæk, Ádám Hulmán	12
5	A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals 2022 ·JCI Insight ·Jonas Jensen, Ole L. Dollerup, Andreas Buch Møller, (unknown), Emilie Dalbram, Sabina Chubanava, Mads V. Damgaard, Ryan W. Dellinger, Kajetan Trôst, Thomas Möritz, Steffen Ringgaard, Niels Møller, Jonas T. Treebak, Jean Farup, Niels Jessen	23
6	Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study 2020 ·Cardiovascular Drugs and Therapy ·(unknown), Henrik Wiggers, Ole L. Dollerup, Nichlas Riise Jespersen, Nils Henrik Hansson, Jørgen Frøkiær, Kim Brøsen, Helene Nørrelund, Hans Erik Bøtker, Niels Møller, Niels Jessen	13
7	Effects of protein intake prior to carbohydrate-restricted endurance exercise: a randomized crossover trial 2020 ·Journal of the International Society of Sports Nutrition ·(unknown), Lars Holm, Mads Svart, Astrid Johannesson Hjelholt, (unknown), Ole L. Dollerup, Line Barner Dalgaard, Mikkel Holm Vendelbo, Gerrit van Hall, Niels Møller, Ulla Ramer Mikkelsen, Mette Hansen	10
8	Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin‐resistant men 2019 ·The Journal of Physiology ·Ole L. Dollerup, Sabina Chubanava, Marianne Agerholm, (unknown), Ali Altıntaş, Andreas Buch Møller, (unknown), Steffen Ringgaard, Hans Stødkilde‐Jørgensen, Gareth G. Lavery, Romain Barrès, Steen Larsen, Clara Prats, Niels Jessen, Jonas T. Treebak	99
9	Acute and sustained effects of a periodized carbohydrate intake using the sleep‐low model in endurance‐trained males 2019 ·Scandinavian Journal of Medicine and Science in Sports ·(unknown), Andreas Buch Møller, Ole L. Dollerup, (unknown), Niels Jessen, Klavs Madsen	15
10	Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity 2019 ·The Journal of Clinical Endocrinology & Metabolism ·Ole L. Dollerup, Samuel A.J. Trammell, Bolette Hartmann, Jens J. Holst, Britt Christensen, Niels Møller, Matthew P. Gillum, Jonas T. Treebak, Niels Jessen	56
11	A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects 2018 ·American Journal of Clinical Nutrition ·Ole L. Dollerup, Britt Christensen, Mads Svart, Mark S. Schmidt, Karolina Sulek, Steffen Ringgaard, Hans Stødkilde‐Jørgensen, Niels Møller, Charles Brenner, Jonas T. Treebak, Niels Jessen	191
12	A Rare Case of Embryonal Carcinoma in a Patient with Turner Syndrome without Y Chromosomal Material but Mutations in <b><i>KIT</i></b>, <b><i>AKT1</i></b>, and <b><i>ZNF358</i></b> Demonstrated Using Exome Sequencing 2017 ·Sexual Development ·Claus Højbjerg Gravholt, Ole L. Dollerup, (unknown), (unknown), Katrine Stribolt, Søren Vang, Britt Elmedal Laursen, Michael Knudsen, Kasper Thorsen, Remko Hersmus, Leendert H. J. Looijenga, Kirstine Stochholm	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact